664 related articles for article (PubMed ID: 10097093)
21. Structural specificity of heparin binding in the fibroblast growth factor family of proteins.
Raman R; Venkataraman G; Ernst S; Sasisekharan V; Sasisekharan R
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2357-62. PubMed ID: 12604799
[TBL] [Abstract][Full Text] [Related]
22. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs.
Mohammadi M; Olsen SK; Goetz R
Curr Opin Struct Biol; 2005 Oct; 15(5):506-16. PubMed ID: 16154740
[TBL] [Abstract][Full Text] [Related]
23. Ligand-binding specificity of human fibroblast growth factor receptor-3 IIIc.
Lin HY; Kaplow J; Jaye M; Hayman MJ
FEBS Lett; 1997 Jul; 411(2-3):389-92. PubMed ID: 9271242
[TBL] [Abstract][Full Text] [Related]
24. Engineering of fibroblast growth factor: alteration of receptor binding specificity.
Seddon AP; Aviezer D; Li LY; Böhlen P; Yayon A
Biochemistry; 1995 Jan; 34(3):731-6. PubMed ID: 7827030
[TBL] [Abstract][Full Text] [Related]
25. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization.
Pantoliano MW; Horlick RA; Springer BA; Van Dyk DE; Tobery T; Wetmore DR; Lear JD; Nahapetian AT; Bradley JD; Sisk WP
Biochemistry; 1994 Aug; 33(34):10229-48. PubMed ID: 7520751
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.
Chellaiah AT; McEwen DG; Werner S; Xu J; Ornitz DM
J Biol Chem; 1994 Apr; 269(15):11620-7. PubMed ID: 7512569
[TBL] [Abstract][Full Text] [Related]
27. FGF-2/fibroblast growth factor receptor/heparin-like glycosaminoglycan interactions: a compensation model for FGF-2 signaling.
Padera R; Venkataraman G; Berry D; Godavarti R; Sasisekharan R
FASEB J; 1999 Oct; 13(13):1677-87. PubMed ID: 10506571
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.
Ibrahimi OA; Eliseenkova AV; Plotnikov AN; Yu K; Ornitz DM; Mohammadi M
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7182-7. PubMed ID: 11390973
[TBL] [Abstract][Full Text] [Related]
29. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
Harmer NJ
Biochem Soc Trans; 2006 Jun; 34(Pt 3):442-5. PubMed ID: 16709182
[TBL] [Abstract][Full Text] [Related]
30. Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis.
Bellosta P; Iwahori A; Plotnikov AN; Eliseenkova AV; Basilico C; Mohammadi M
Mol Cell Biol; 2001 Sep; 21(17):5946-57. PubMed ID: 11486033
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of a fibroblast growth factor (FGF) binding domain in the cysteine-rich FGF receptor.
Zhou Z; Zuber ME; Burrus LW; Olwin BB
J Biol Chem; 1997 Feb; 272(8):5167-74. PubMed ID: 9030584
[TBL] [Abstract][Full Text] [Related]
32. Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor.
Berman B; Ostrovsky O; Shlissel M; Lang T; Regan D; Vlodavsky I; Ishai-Michaeli R; Ron D
J Biol Chem; 1999 Dec; 274(51):36132-8. PubMed ID: 10593896
[TBL] [Abstract][Full Text] [Related]
33. A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors.
Filion RJ; Popel AS
Ann Biomed Eng; 2004 May; 32(5):645-63. PubMed ID: 15171620
[TBL] [Abstract][Full Text] [Related]
34. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
Ruohola JK; Valve EM; Vainikka S; Alitalo K; Härkönen PL
Endocrinology; 1995 May; 136(5):2179-88. PubMed ID: 7536664
[TBL] [Abstract][Full Text] [Related]
35. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex.
McKeehan WL; Wu X; Kan M
J Biol Chem; 1999 Jul; 274(31):21511-4. PubMed ID: 10419453
[TBL] [Abstract][Full Text] [Related]
36. The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity.
Harmer NJ; Pellegrini L; Chirgadze D; Fernandez-Recio J; Blundell TL
Biochemistry; 2004 Jan; 43(3):629-40. PubMed ID: 14730967
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs.
Olsen SK; Garbi M; Zampieri N; Eliseenkova AV; Ornitz DM; Goldfarb M; Mohammadi M
J Biol Chem; 2003 Sep; 278(36):34226-36. PubMed ID: 12815063
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction.
Vainikka S; Partanen J; Bellosta P; Coulier F; Birnbaum D; Basilico C; Jaye M; Alitalo K
EMBO J; 1992 Dec; 11(12):4273-80. PubMed ID: 1385111
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans.
Venkataraman G; Shriver Z; Davis JC; Sasisekharan R
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1892-7. PubMed ID: 10051565
[TBL] [Abstract][Full Text] [Related]
40. Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.
Venkataraman G; Sasisekharan V; Herr AB; Ornitz DM; Waksman G; Cooney CL; Langer R; Sasisekharan R
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):845-50. PubMed ID: 8570646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
